Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers

Saudi Medical Journal

Volumn 25, Issue 8, 2004, Pages 1006-1009

  Ghazzawi, Imad M ^a,b   Obeidat, Walid A ^a   Zuriekat, Feras A ^a  

^a KING HUSSEIN MEDICAL CENTER   (Jordan)

^b NONE   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PANTOPRAZOLE; PARACETAMOL;

ADULT; ARTICLE; BACTERIUM CULTURE; CAMPYLOBACTER; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DUODENOSCOPY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; HEADACHE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; JORDAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OPEN STUDY; PROSPECTIVE STUDY; XEROSTOMIA;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMOXICILLIN; BENZIMIDAZOLES; CLARITHROMYCIN; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JORDAN; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SULFOXIDES; TREATMENT OUTCOME;

EID: 4544332595     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-1275.
2. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
3. Kuipers EJ. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1997; 11 (Suppl 1): 71-88.
4. Neil GA. Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era. Am J Gastroenterol 1997; 92: 387-393.
5. Peek RM Jr, Blaser MJ. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med 1997; 102: 200-207.
6. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89 (8 Suppl): S116-S128.
7. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192-199.
8. Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991; 32: 1415-1418.
9. Sonnenberg A, Everhart JE. The prevalence of self-reported peptic ulcer in the United States. Am J Public Health 1996; 86: 200-205.
10. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10: 720-741.
11. Graham DY, Rabeneck L. Patients, payers, and paradigm shifts: what to do about Helicobacter pylori [editorial]. Am J Gastroenterol 1996; 91:188-190.
12. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186.
13. Sharma P, Topalovski M, Mayo MS, Sampliner RE, Weston AP et al. Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia. Am J Gastroenterol 2000; 95: 3107-3111.
14. +-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998; 115: 340-347.
15. Stedman CAM, Barclay ML. Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 963.
16. Huber R, Kohl B, Sachs G, Senn-Bilfinger J, Simon WA, Sturm E et al. The continuing development of proton pump inhibitors with particular reference to pantoprazole. Aliment Pharmacol Ther 1995; 9: 363-378.
17. Huber R, Hartmann M, Bliesath H, Luhmann R, Steinijans VW, Zech K et al. Pharmacokinetics of pantoprazole in man. Int J Clin Pharmacol Ther 1996; 34: 185-194.
18. Kromer W. Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds. Digestion 1995; 56: 443-454.
19. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995; 109: 136-141.
20. Cutler AF. Testing for Helicobacter pylori in clinical practice. Am J Med 1996; 100: 35S-39S.
21. Vakil N, Rhew D, Soll A, Ofman JJ. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori. Am J Gastroenterol 2000; 95: 1691-1698.
22. Glupczynski Y. The diagnosis of Helicobacter pylori infection: a microbiologist's perspective. Rev Med Microbiol 1994; 5: 199-208. (translated abstract)
23. Laine L, Chun D, Stein C, El-Beblawi I, Sharma V, Chandrasoma P et al. The influence of size or number of biopsies on rapid urease test results: a prospective evaluation. Gastrointest Endosc 1996; 43: 49-53.
24. Greenberg PD, Koch J, Cello JP. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers. Am J Gastroenterol 1996; 91: 228-232.
25. Graham DY, De Boer WA, Tytgat GN. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol 1996; 91: 1072-1076.
26. Hunt RH. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori. Am J Gastroenterol 1997; 92 (4 Suppl): 36S-43S.
27. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. Gut 1997; 41: 8-13.
28. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus report. Aliment Pharmacol Ther 2002; 16: 167-180.
29. Porro GB, Lazzaroni M, Bargiggia S, Maconi G, Trespi E, Perego M et al. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. Am J Gastroenterol 1996; 91: 695-700.
30. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, O'Morain C, Cooper BT et al. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut 1997; 41: 735-739.
31. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K et al. Effects of ranitidine and amoxicillin plus metronidazole on the eradication of H. pylori and the recurrence of ulcer. N Engl J Med 1993; 328: 308-311.